Government updates

Government updates

Most recent update

The Government has published its reasonable worst-case scenario planning assumptions for borders at the end of the transition period on 31st December 2020.

The Department of Health and Social Care is working with the medicines supply chain in the UK to mitigate any disruption in the continuity of supply of medicines, medical devices and medical consumables. Mitigations include a request to manufacturers and suppliers to increase their medicines stocks by at least 6 weeks on top of their usual buffer stocks and ensure plans are in place to air freight products with a short shelf life.

Read more about Government Brexit planning

Previous updates

4th August 2020: DHSC plans for end of Transition Period
In a letter to suppliers of medicines and medicinal products, DHSC’s Chief Commercial Officer Steve Oldfield set out the Government’s preparations alongside its expectations of the industry in the run up to 31st December 2020. This includes requests to aim to hold six weeks’ worth of stock in the UK and to urgently review their own contingency plans for the possibility of a worst-case scenario.

31st January 2020
The UK left the European Union (EU) on Friday 31st January 2020 and entered a transition period until the end of 2020 whilst additional arrangements are negotiated. The GOV.UK website states that, during the transition period, the current rules on trade, travel, and business for the UK and EU will continue to apply.

Letter to the health and social care industry from Chief Commercial Officer Steve Oldfield

31st October 2019: EU Exit Date Extended
The UK and the EU have agreed an extension of the Article 50 period until 31 January 2020. The Department of Health and Social Care (DHSC) said it is making the necessary changes to accommodate this and will provide additional guidance about any next steps as and when they are published.

Read the letter in full here

NHSE&I has issued a similar letter

10th October 2019: DHSC update on continuity of medicines supply
Secretary of State for Health and Social Care, Matt Hancock, provided an update to Parliament on the Department’s contingency planning for the supply of medicines and medical products following a no-deal Brexit.

20th September 2019: Important update for pharmacies
As we head towards the UK’s planned exit from the European Union, the Government’s guidance and messaging for the public and those involved in the medicines supply chain has evolved. This article provides a round-up of recent events that community pharmacy teams need to be aware of.

12th September 2019: Government publishes worst case scenarios
The Government has released details of its planning for a no-deal Brexit (known as ‘Operation Yellowhammer’) following a Parliamentary motion requesting the documentation be made public.

16th August 2019: DHSC bolster no-deal planning with express freight service
DHSC announced the creation of an express freight service for medicines as part of contingency planning for a no-deal Brexit. The new freight service will be available to transport medicines and medical products into the UK quickly and is intended to provide an extra level of protection to the medicines supply chain in a no-deal scenario.

2nd August 2019: Government increases funding allocation for no-deal Brexit preparations
HM Government committed funding to help make sure that all industries and businesses are ready if we leave without a deal, with £434 million for the continuity of medicines supply. Whilst PSNC welcomed this announcement, it should be noted that DHSC has been working closely with representatives of medicines manufacturers and pharmacies for almost a year to put robust plans in place for a possible no-deal Brexit.

26th June 2019: Government update letter
This is a letter to suppliers giving an update on ensuring a continued supply of medicines and medical products if the UK leaves the EU with no deal. The letter sets out:

  • how the government plans to ensure a continued supply of medicines and medical products; and
  • how suppliers of those products can best prepare.

10th April 2019: NHS England issues additional guidance for primary care contractors
NHS England published a letter to support primary care contractors in preparing for the possibility of a no-deal Brexit. Written by EU Exit Strategic Commander Professor Keith Willett and Director of Primary Care Commissioning Dr David Geddes, the letter provides advice on medicines supply and who to raise concerns to. It also offers some clarification on the use of Serious Shortage Protocols (SSPs).

4th April 2019: Health Secretary provides update
The Secretary of State for Health and Social Care wrote to frontline health professionals to provide an update on the Government’s Brexit preparations. Mr Hancock’s letter outlines the most recent information on key healthcare issues relating to the UK’s exit from the EU. It reiterates Government advice stating local stockpiling is unnecessary, confirms the continued recognition of EU professional qualifications in the UK, and highlights the EU Settlement Scheme.

Read Matt Hancock’s letter to health and social care staff

26th March 2019: DHSC communication on EU exit date
Stakeholder communications were issued confirming that the Government has agreed an extension to Article 50. DHSC is continuing work on its no-deal preparations, now planning for the possibility of a no-deal scenario from 12th April 2019.

DHSC told stakeholders: “Please continue the work you are undertaking to prepare your organisation for leaving the EU without a deal and do not wind-down your contingency plans at this stage. You may need to make changes to stop your no deal plans coming into force on 29th March and re-programme preparations to be ready for 12th April.”

25th February 2019: DHSC update on Brexit and the medicine supply chain
The Government issued an update on its contingency planning for a no-deal Brexit via a written statement to Parliament from Minister Stephen Hammond MPThe key message is that the DHSC has been working closely with industry stakeholders to undertake considerable contingency planning for any UK exit from the EU with no ratified deal (a no-deal Brexit). The contingency plans are being made to ensure the continuity of the supply of medicines to patients in the UK.

For more information, see Update on medicines and medical products supply as we exit the EU.

21st December 2018: Operational Readiness Guidance
DHSC has developed new EU Exit Operational Readiness Guidance for providers of NHS services. The guidance, developed with NHS England and NHS Improvement, is part of the Department’s work to ramp up preparations for a possible no-deal Brexit. PSNC is supporting the Government’s Brexit planning and we are working closely with the other pharmacy organisations to consider what this guidance means in practice for community pharmacies. We will issue further advice in due course, but contractors are advised to familiarise themselves with DHSC’s messages.

Read the DHSC Letter to All Providers and Commissioners of NHS Services

Read the EU Exit Operational Readiness Guidance

Visit the page containing all relevant information from DHSC

PSNC has since identified the key actions from this DHSC guidance for contractors in PSNC Briefing 005/19: Key actions for pharmacy contractors to prepare for a no-deal exit from the EU.

7th December 2018: Health Secretary letter to healthcare professionals
Health Secretary Matt Hancock has written to frontline healthcare professionals, stressing the need to avoid local stockpiling of medicines, saying: “UK health and social care providers – including hospitals, care homes, GPs and community pharmacies – should not stockpile additional medicines beyond their business as usual stock levels. There is also no need for clinicians to write longer NHS prescriptions”. He also said that, if asked, they should advise their patients against stockpiling medicines. In summary, the guidance states that:

  1. Community pharmacies (along with other healthcare providers) should not stockpile additional medicines beyond their business as usual stock levels;
  2. There is no need for clinicians to write longer NHS prescriptions;
  3. Local stockpiling is unnecessary and could cause shortages in other areas, which would put patient care at risk;
  4. Any incidences involving the over-ordering of medicines would be investigated and followed up with the relevant Chief or Responsible Pharmacist directly; and
  5. If asked, patients should be advised not to store additional medicines at home because the Government is working with industry to ensure a continued supply of medicines.

Read the Secretary of State’s letter to frontline healthcare professionals

23rd August 2018: Letter sent by DHSC to frontline healthcare professionals
DHSC has written a letter advising community pharmacies that they “do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels.” Instead, pharmaceutical companies are being asked to hold an additional six weeks supply. PSNC’s Brexit Forum will be monitoring the impact of DHSC’s stockpiling contingency plans on medicine prices.

Read the letter sent by DHSC to frontline healthcare professionals

Return to the Brexit and Community Pharmacy index page.

Latest Contract & IT news

View more Contract & IT news >

Christmas Bank Holiday Opening

In today’s Primary Care Bulletin email, NHS England and NHS Improvement (NHSE&I) confirmed that there is currently no intention to...